Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
FDA, CDC lift recommended pause on the use of Janssen COVID-19 vaccine in the U.S.

FDA, CDC lift recommended pause on the use of Janssen COVID-19 vaccine in the U.S.

SARS-CoV-2 vaccine with single-cycle adenovirus vector

SARS-CoV-2 vaccine with single-cycle adenovirus vector

Humoral immunity developed by DNA vaccine INO-4800 is effective against SARS-CoV-2 variants

Humoral immunity developed by DNA vaccine INO-4800 is effective against SARS-CoV-2 variants

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

Speed of vaccination is key to reducing COVID-19 spread, says study

Speed of vaccination is key to reducing COVID-19 spread, says study

Researchers work to develop dual antigen COVID-19 vaccine candidate

Researchers work to develop dual antigen COVID-19 vaccine candidate

Oxford-AstraZeneca COVID vaccine induces cell spikes similar to SARS-CoV-2's

Oxford-AstraZeneca COVID vaccine induces cell spikes similar to SARS-CoV-2's

Can limiting the priming dose of a SARS-CoV-2 vaccine improve immunity?

Can limiting the priming dose of a SARS-CoV-2 vaccine improve immunity?

South Africa SARS-CoV-2 variant B.1.351 easily escapes Sputnik vaccine

South Africa SARS-CoV-2 variant B.1.351 easily escapes Sputnik vaccine

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

New portable viral screening test can diagnose COVID-19 in minutes and track variants

New portable viral screening test can diagnose COVID-19 in minutes and track variants

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

GMP-Ready Helper Plasmids for AAV Production

GMP-Ready Helper Plasmids for AAV Production

Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients

Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients

Is a single mRNA COVID-19 vaccine dose enough for recovered individuals?

Is a single mRNA COVID-19 vaccine dose enough for recovered individuals?

New academic spin-out based in Finland introduces a nasal spray vaccine against COVID

New academic spin-out based in Finland introduces a nasal spray vaccine against COVID

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines